XRL

4-[(9-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzonitrile

Created:	2022-12-06
Last modified:	2023-02-01

Find Related PDB Entry
1 entries where XRL is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	54
Chiral Atom Count	0
Bond Count	57
Aromatic Bond Count	18

2D diagram of XRL

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(9-{4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]benzonitrile
Systematic Name (OpenEye OEToolkits)	4-[[9-[4-[(~{E})-2-cyanoethenyl]-2,6-dimethyl-phenyl]-6-oxidanylidene-7,8-dihydro-5~{H}-pyrimido[4,5-b][1,4]diazepin-2-yl]amino]benzenecarbonitrile
Formula	C₂₅ H₂₁ N₇ O
Molecular Weight	435.481
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N#Cc1ccc(cc1)Nc1nc2c(NC(=O)CCN2c2c(C)cc(\C=C\C#N)cc2C)cn1
SMILES	CACTVS	3.385	Cc1cc(C=CC#N)cc(C)c1N2CCC(=O)Nc3cnc(Nc4ccc(cc4)C#N)nc23
SMILES	OpenEye OEToolkits	2.0.7	Cc1cc(cc(c1N2CCC(=O)Nc3c2nc(nc3)Nc4ccc(cc4)C#N)C)C=CC#N
Canonical SMILES	CACTVS	3.385	Cc1cc(/C=C/C#N)cc(C)c1N2CCC(=O)Nc3cnc(Nc4ccc(cc4)C#N)nc23
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1cc(cc(c1N2CCC(=O)Nc3c2nc(nc3)Nc4ccc(cc4)C#N)C)/C=C/C#N
InChI	InChI	1.06	InChI=1S/C25H21N7O/c1-16-12-19(4-3-10-26)13-17(2)23(16)32-11-9-22(33)30-21-15-28-25(31-24(21)32)29-20-7-5-18(14-27)6-8-20/h3-8,12-13,15H,9,11H2,1-2H3,(H,30,33)(H,28,29,31)/b4-3+
InChIKey	InChI	1.06	CXONFCILERVPJH-ONEGZZNKSA-N

Related Resource References

Resource Name	Reference
PubChem	166513922

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.